SCHEMBL932685

SCHEMBL932685

N=C(c1cccc(Br)c1)c1ccc2c(c1)OCCO2

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.57
RAB9A P51151 4/20 0.57
MAOB P27338 3/20 0.57
MAPT P10636 5/20 0.52
MEN1 O00255 1/20 0.52
GAA P10253 1/20 0.52
KMT2A Q03164 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
LMNA P02545 2/20 0.50
ALDH1A1 P00352 1/20 0.50
ALOX12 P18054 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
HTT P42858 1/20 0.49
BLM P54132 1/20 0.49
PKM P14618 1/20 0.48
CTNNB1 P35222 4/20 0.47
NPSR1 Q6W5P4 1/20 0.47
ATM Q13315 2/20 0.46
TSHR P16473 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4784460 0.84 NPC1 (0.64) NPC1RAB9AMAOBMAPTMEN1
SCHEMBL21980363 0.76 NPC1 (0.57) NPC1RAB9AMAOBMAPTMEN1
SCHEMBL2281973 0.75 NPC1 (0.57) NPC1RAB9AMAOBMAPTMEN1
SCHEMBL15425129 0.73 RAB9A (0.55) NPC1RAB9AMAOBMAPTMEN1
SCHEMBL19006231 0.73 RAB9A (0.55) NPC1RAB9AMAOBMAPTMEN1
SCHEMBL1660203 0.72 CTNNB1 (0.61) NPC1RAB9AMAOBMAPTMEN1
SCHEMBL14154999 0.71 MAPT (0.56) NPC1RAB9AMAOBMAPTMEN1
SCHEMBL931503 0.71 C1S (0.53) MAOBMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL661042 0.71 MAPT (0.87) NPC1RAB9AMAOBMAPTMEN1
SCHEMBL20572734 0.71 TSHR (0.67) NPC1RAB9AMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011002407-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed
WO-2011002407-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed